AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29696403 — intervention group
Group type: EXPERIMENTAL
Intervention: Guy2Guy text messaging based HIV prevention program
Number of subjects: 302
Study 29696403 — intervention group
Group type: COMPARATOR
Intervention: Attention-matched control program
Number of subjects: 302
Study 27959766 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring (25 mg)
Number of subjects: 1959
Study 27959766 — intervention group
Group type: COMPARATOR
Intervention: Placebo vaginal ring
Number of subjects: 1959
Study 24820300 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-site surgery
Number of subjects: 54
Study 24820300 — intervention group
Group type: COMPARATOR
Intervention: Three-port surgery
Number of subjects: 54
Study 24820300 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 54
Study 22385074 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream for 4 weeks before Mohs micrographic surgery (MMS)
Number of subjects: 70
Study 22385074 — intervention group
Group type: COMPARATOR
Intervention: Control group (MMS only)
Number of subjects: 70
Study 22385074 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream for 4 weeks before MMS
Number of subjects: 70
Study 20399360 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoperative treatment (medications, physical therapy, lumbar injection)
Number of subjects: 0
Study 20399360 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical intervention (lumbar discectomy)
Number of subjects: 0
Study 18339002 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise (hiking downwards)
Number of subjects: 45
Study 18339002 — intervention group
Group type: COMPARATOR
Intervention: Concentric exercise (hiking upwards)
Number of subjects: 45
Study 16239154 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication for 5 weeks, followed by combined medication plus CBT for 5 weeks
Number of subjects: 17
Study 16239154 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment for 5 weeks, followed by CBT alone
Number of subjects: 17
Study 16239154 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT alone
Number of subjects: 17
Study 11940259 — intervention group
Group type: EXPERIMENTAL
Intervention: High quality research evidence
Number of subjects: 0
Study 11940259 — intervention group
Group type: EXPERIMENTAL
Intervention: Translational barriers
Number of subjects: 0
Study 11940259 — intervention group
Group type: EXPERIMENTAL
Intervention: Emerging therapies in critical care
Number of subjects: 0
Study 10862229 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (determination of baseline CK level, CK MB fraction, cTnI level, and myoglobin level at baseline and at 2 hours)
Number of subjects: 296
Study 10862229 — intervention group
Group type: COMPARATOR
Intervention: Control group (determination of baseline CK level and CK MB fraction)
Number of subjects: 296
Study 10862229 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 296
Study 9505999 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin 250 mg taken orally 4 times daily
Number of subjects: 10
Study 8180726 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE-inhibitors (enalapril and lisinopril)
Number of subjects: 6600
Study 8180726 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium antagonists (isradipine and felodipine)
Number of subjects: 6600
Study 8180726 — intervention group
Group type: COMPARATOR
Intervention: Beta-blockers and/or diuretics
Number of subjects: 6600
Study 3540872 — intervention group
Group type: EXPERIMENTAL
Intervention: Zomepirac 100 mg
Number of subjects: 88
Study 3540872 — intervention group
Group type: COMPARATOR
Intervention: Meperidine 100 mg
Number of subjects: 88
Study 3540872 — intervention group
Group type: COMPARATOR
Intervention: Meperidine 50 mg
Number of subjects: 88
Study 31720808 — intervention group
Group type: EXPERIMENTAL
Intervention: Expiratory Muscle Training (EMT) + Air Stacking (AS)
Number of subjects: 33
Study 31720808 — intervention group
Group type: COMPARATOR
Intervention: Expiratory Muscle Training (EMT)
Number of subjects: 33
Study 31720808 — intervention group
Group type: COMPARATOR
Intervention: Control (fixed resistance EMT)
Number of subjects: 33
Study 29948585 — intervention group
Group type: EXPERIMENTAL
Intervention: Proliferative scar group
Number of subjects: 0
Study 29948585 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 26840653 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab therapy
Number of subjects: 26
Study 24514432 — intervention group
Group type: EXPERIMENTAL
Intervention: Unbalanced crystalloid (chloride: 155.5 mmol/l)
Number of subjects: 40
Study 24514432 — intervention group
Group type: COMPARATOR
Intervention: Balanced crystalloid and balanced colloid (6% w/v hydroxyethyl starch 130/0.42; chloride: 98 and 112 mmol/l)
Number of subjects: 40
Study 22953991 — intervention group
Group type: COMPARATOR
Intervention: 30 mCi 131I alone (Group A)
Number of subjects: 61
Study 22953991 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mCi 131I plus lithium 900 mg/day for 7 days (Group B)
Number of subjects: 61
Study 21106618 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated motivational interviewing and cognitive behavioural therapy plus standard care
Number of subjects: 327
Study 21106618 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 327
Study 18366445 — intervention group
Group type: EXPERIMENTAL
Intervention: Nevirapine-containing combination antiretroviral therapy (NcART)
Number of subjects: 410
Study 15695788 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iodinated contrast agent (used in part I and part II)
Number of subjects: 54
Study 15695788 — intervention group
Group type: COMPARATOR
Intervention: Non-contrast PET scan (used in part I)
Number of subjects: 54
Study 15695788 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited plain CT scan followed by WB intravenous contrast CT scan (used in part II)
Number of subjects: 54
Study 12642963 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar-coated tablet (50 mg opipramol-2HCl)
Number of subjects: 38
Study 12642963 — intervention group
Group type: COMPARATOR
Intervention: Aqueous solution (50 mg opipramol-2HCl)
Number of subjects: 38
Study 12642963 — intervention group
Group type: EXPERIMENTAL
Intervention: Film-coated tablet (100 mg opipramol-2HCl)
Number of subjects: 38
Study 12642963 — intervention group
Group type: COMPARATOR
Intervention: Sugar-coated tablet (100 mg opipramol-2HCl)
Number of subjects: 38
Study 11220871 — intervention group
Group type: EXPERIMENTAL
Intervention: Grandaxine in combination with standard therapy
Number of subjects: 59
Study 11220871 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (control group)
Number of subjects: 59
Study 8641115 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 5 mg day‐1
Number of subjects: 62
Study 8641115 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 62
Study 30610915 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 Gy in 12 fractions
Number of subjects: 12
Study 30610915 — intervention group
Group type: EXPERIMENTAL
Intervention: 26.4 Gy in 12 fractions
Number of subjects: 12
Study 30610915 — intervention group
Group type: EXPERIMENTAL
Intervention: 30.8 Gy in 14 fractions
Number of subjects: 12
Study 30610915 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 12
Study 30185008 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior segmental decompression
Number of subjects: 84
Study 30185008 — intervention group
Group type: COMPARATOR
Intervention: Posterior laminoplasty
Number of subjects: 84
Study 25039702 — intervention group
Group type: EXPERIMENTAL
Intervention: Z‐track technique
Number of subjects: 75
Study 25039702 — intervention group
Group type: EXPERIMENTAL
Intervention: Internally rotated foot technique
Number of subjects: 75
Study 25039702 — intervention group
Group type: COMPARATOR
Intervention: Standard injection technique
Number of subjects: 75
Study 24729586 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2A6 -48T→G polymorphism
Number of subjects: 84
Study 24729586 — intervention group
Group type: EXPERIMENTAL
Intervention: UGT2B7 735 G/G homozygosity
Number of subjects: 84
Study 24729586 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2A6 -48T→G and UGT2B7 735 G/G homozygosity (multivariable model)
Number of subjects: 84
Study 22335390 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX 0.5 μg/kg in 10 mL isotonic saline
Number of subjects: 300
Study 22335390 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX 1 μg/kg in 10 mL isotonic saline
Number of subjects: 300
Study 22335390 — intervention group
Group type: COMPARATOR
Intervention: 10 mL isotonic saline (control group)
Number of subjects: 300
Study 18476416 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture-general anesthesia (Group B)
Number of subjects: 60
Study 18476416 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (Group A)
Number of subjects: 60
Study 16642609 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment group (acupuncture + Xingnaojing injection)
Number of subjects: 125
Study 16642609 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture group
Number of subjects: 125
Study 16642609 — intervention group
Group type: EXPERIMENTAL
Intervention: Xingnaojing group
Number of subjects: 125
Study 16642609 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine treatment group
Number of subjects: 125
Study 14600850 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at GV 20 and ST 36 bilaterally
Number of subjects: 61
Study 14600850 — intervention group
Group type: COMPARATOR
Intervention: Control group (no acupuncture)
Number of subjects: 61
Study 10742438 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 units of avicatonin intramuscularly injected once a week for 4 consecutive weeks
Number of subjects: 18
Study 10742438 — intervention group
Group type: COMPARATOR
Intervention: Inactive placebo intramuscularly injected once a week for 4 consecutive weeks
Number of subjects: 18
Study 9181206 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated telephone reminders
Number of subjects: 701
Study 9181206 — intervention group
Group type: COMPARATOR
Intervention: Control group (no reminders)
Number of subjects: 701
Study 1584592 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical lidocaine (5 ml of 2% lidocaine)
Number of subjects: 14
Study 1584592 — intervention group
Group type: COMPARATOR
Intervention: Saline (5 ml saline)
Number of subjects: 14
Study 4037063 — intervention group
Group type: EXPERIMENTAL
Intervention: Bausch and Lomb IVEX (Integrated Vision Examination System)
Number of subjects: 40
Study 4037063 — intervention group
Group type: COMPARATOR
Intervention: Conventional clinical refraction
Number of subjects: 40
Study 29534465 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein supplement (whey isolate and beef hydrolysate)
Number of subjects: 12
Study 29534465 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin (control)
Number of subjects: 12
Study 27586071 — intervention group
Group type: EXPERIMENTAL
Intervention: PATHS curriculum
Number of subjects: 4516
Study 27586071 — intervention group
Group type: COMPARATOR
Intervention: Usual provision (control)
Number of subjects: 4516
Study 25178668 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor (180 mg loading dose)
Number of subjects: 92
Study 25178668 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (600 mg loading dose)
Number of subjects: 92
Study 22235888 — intervention group
Group type: EXPERIMENTAL
Intervention: Gel containing niosomes entrapped with rice bran bioactive compounds
Number of subjects: 30
Study 22235888 — intervention group
Group type: EXPERIMENTAL
Intervention: Cream containing niosomes entrapped with rice bran bioactive compounds
Number of subjects: 30
Study 22235888 — intervention group
Group type: COMPARATOR
Intervention: Closed patch test on shaved rabbit skin
Number of subjects: 30
Study 19694994 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients receiving blood transfusions (n = 25)
Number of subjects: 127
Study 19694994 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 30)
Number of subjects: 127
Study 19694994 — intervention group
Group type: EXPERIMENTAL
Intervention: Athletes (n = 127)
Number of subjects: 127
Study 19694994 — intervention group
Group type: EXPERIMENTAL
Intervention: Nontransfused hospitalized patients (n = 39)
Number of subjects: 127
Study 18520803 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT‐751 200 mg daily for 21 consecutive days, followed by 7 days off drug
Number of subjects: 35
Study 18520803 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT‐751
Number of subjects: 35
Study 16529564 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (pelvic floor muscle training and duloxetine)
Number of subjects: 0
Study 16529564 — intervention group
Group type: COMPARATOR
Intervention: No active treatment
Number of subjects: 0
Study 12834994 — intervention group
Group type: EXPERIMENTAL
Intervention: Older siblings smoking
Number of subjects: 2981
Study 11023929 — intervention group
Group type: EXPERIMENTAL
Intervention: t-PA
Number of subjects: 15059
Study 11023929 — intervention group
Group type: EXPERIMENTAL
Intervention: r-PA
Number of subjects: 15059
Study 8850108 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril treatment
Number of subjects: 2231
Study 8850108 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 2231
Study 1346745 — intervention group
Group type: EXPERIMENTAL
Intervention: verapamil 0.05 mg kg‐1
Number of subjects: 3
Study 1346745 — intervention group
Group type: EXPERIMENTAL
Intervention: verapamil 0.1 mg kg‐1
Number of subjects: 3
Study 1346745 — intervention group
Group type: COMPARATOR
Intervention: saline (control)
Number of subjects: 3
Study 1346745 — intervention group
Group type: EXPERIMENTAL
Intervention: verapamil (both doses)
Number of subjects: 3
Study 6513620 — intervention group
Group type: EXPERIMENTAL
Intervention: Review of audit results only
Number of subjects: 3
Study 6513620 — intervention group
Group type: EXPERIMENTAL
Intervention: Criteria setting and review of audit results
Number of subjects: 3
Study 6513620 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment) in phase 1, then received concurrent reminders in phase 2
Number of subjects: 3
Study 6513620 — intervention group
Group type: EXPERIMENTAL
Intervention: Criteria setting and review of audit results (previously involved in phase 1)
Number of subjects: 3
Study 31984623 — intervention group
Group type: EXPERIMENTAL
Intervention: SGLT2‐i tofogliflozin (TOFO)
Number of subjects: 419
Study 31984623 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 419
Study 30373781 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus tablets combined with quadruple therapy
Number of subjects: 526
Study 30373781 — intervention group
Group type: COMPARATOR
Intervention: Quadruple therapy
Number of subjects: 526
Study 27412146 — intervention group
Group type: EXPERIMENTAL
Intervention: nVNS
Number of subjects: 59
Study 27412146 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 59
Study 27412146 — intervention group
Group type: EXPERIMENTAL
Intervention: nVNS (open-label phase)
Number of subjects: 59
Study 25233647 — intervention group
Group type: EXPERIMENTAL
Intervention: Guan's quadruple therapy for kidney disease
Number of subjects: 80
Study 25233647 — intervention group
Group type: COMPARATOR
Intervention: Conventional western medication
Number of subjects: 80
Study 22622628 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate administered for one week
Number of subjects: 57
Study 22622628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 19935427 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivationally enhanced cardiac rehabilitation (CR)
Number of subjects: 91
Study 19935427 — intervention group
Group type: COMPARATOR
Intervention: Traditional cardiac rehabilitation (CR)
Number of subjects: 91
Study 19935427 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined study group (both CR types)
Number of subjects: 91
Study 18666804 — intervention group
Group type: EXPERIMENTAL
Intervention: FDC tablet of repaglinide/metformin 2 mg/500 mg
Number of subjects: 93
Study 16883914 — intervention group
Group type: EXPERIMENTAL
Intervention: Radix Astragali Injection
Number of subjects: 80
Study 16883914 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (control)
Number of subjects: 80
Study 12860338 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG bioactive/hCG immunoactive ratio
Number of subjects: 36
Study 12860338 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum progesterone
Number of subjects: 36
Study 10938212 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally sensitive program for parent-child communication, including information about tobacco and alcohol effects, social skills training, and parent-child communication skills development.
Number of subjects: 660
Study 10938212 — intervention group
Group type: COMPARATOR
Intervention: Culturally sensitive program for parent-child communication
Number of subjects: 660
Study 8828744 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-dose didanosine (750 mg per day for patients > or = 60 kg)
Number of subjects: 1775
Study 8828744 — intervention group
Group type: COMPARATOR
Intervention: Lower-dose didanosine (200 mg per day)
Number of subjects: 1775
Study 8828744 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-dose didanosine
Number of subjects: 1775
Study 8828744 — intervention group
Group type: COMPARATOR
Intervention: Lower-dose didanosine
Number of subjects: 1775
Study 1601535 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose study
Number of subjects: 0
Study 1601535 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-dose study
Number of subjects: 0
Study 3933861 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine (10 mg)
Number of subjects: 6
Study 3933861 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine (20 mg)
Number of subjects: 6
Study 3933861 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine (30 mg)
Number of subjects: 6
Study 3933861 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine (40 mg)
Number of subjects: 6
Study 30385613 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib
Number of subjects: 295
Study 30385613 — intervention group
Group type: COMPARATOR
Intervention: Sorafenib and placebo
Number of subjects: 295
Study 31223014 — intervention group
Group type: EXPERIMENTAL
Intervention: Management model and safe practice from 2005-2016 including emergency diagnostic procedures, colour-Doppler, arteriography, emergency surgery (embolectomy by Fogharty and if necessary, vascular by-pass)
Number of subjects: 100
Study 31223014 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment method from 2000-2005
Number of subjects: 100
Study 28028723 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenfu Injection (SFI) treatment (100 mL/24 h)
Number of subjects: 60
Study 25576680 — intervention group
Group type: EXPERIMENTAL
Intervention: <2 g sodium diet education
Number of subjects: 305
Study 25576680 — intervention group
Group type: EXPERIMENTAL
Intervention: <2 g sodium diet education (2 samples)
Number of subjects: 305
Study 25576680 — intervention group
Group type: EXPERIMENTAL
Intervention: Male sex and higher BMI
Number of subjects: 305
Study 23364361 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedative instrumental music (60-80 beats per minute)
Number of subjects: 120
Study 21742306 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotic membrane transplantation (AMT)
Number of subjects: 42
Study 21742306 — intervention group
Group type: COMPARATOR
Intervention: Conjunctival autograft
Number of subjects: 42
Study 19919714 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoke exposure in small airway epithelium
Number of subjects: 155
Study 19919714 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoke exposure in alveolar macrophages
Number of subjects: 155
Study 19919714 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathway analysis of airway epithelium
Number of subjects: 155
Study 19919714 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathway analysis of alveolar macrophages
Number of subjects: 155
Study 16922700 — intervention group
Group type: EXPERIMENTAL
Intervention: X-PERT Programme (n = 157)
Number of subjects: 314
Study 16922700 — intervention group
Group type: COMPARATOR
Intervention: Control group (individual appointments, n = 157)
Number of subjects: 314
Study 15130591 — intervention group
Group type: EXPERIMENTAL
Intervention: Counting circles
Number of subjects: 22
Study 15130591 — intervention group
Group type: EXPERIMENTAL
Intervention: Counting emotional scenes
Number of subjects: 22
Study 15130591 — intervention group
Group type: COMPARATOR
Intervention: Emotional stimuli
Number of subjects: 22
Study 15130591 — intervention group
Group type: COMPARATOR
Intervention: Neutral stimuli
Number of subjects: 22
Study 11780705 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based computer-tailored nutrition education
Number of subjects: 0
Study 11780705 — intervention group
Group type: COMPARATOR
Intervention: General nutrition information (Control)
Number of subjects: 0
Study 9416888 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril (2.5 to 5 up to 10 mg/d) with or without nitroglycerin (5 to 20 microg I.V. then 10 mg/d)
Number of subjects: 2790
Study 8269890 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegan diet (uncooked 'living food') for 3 months, tutored daily by a living-food expert.
Number of subjects: 43
Study 8269890 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual diet, no tutoring).
Number of subjects: 43
Study 8269890 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegan diet group.
Number of subjects: 43
Study 3114203 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin-releasing hormone (GnRH) 500 micrograms
Number of subjects: 5
Study 3114203 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 29477629 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-literacy version of the Medicaid Sterilization Consent Form
Number of subjects: 200
Study 29477629 — intervention group
Group type: COMPARATOR
Intervention: Standard version of the Medicaid Sterilization Consent Form
Number of subjects: 200
Study 26438785 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound examination of pleural cavities and inferior vena cava (IVC) by nurses
Number of subjects: 62
Study 26438785 — intervention group
Group type: COMPARATOR
Intervention: Standard clinical examination without ultrasound
Number of subjects: 62